Skip to main content
Log in

Growth in drug expenditure in EU5 countries likely to decrease

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. formerly Quintiles IMS

Reference

  • Espin J, et al. Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates. Applied Health Economics and Health Policy : 7 Aug 2018. Available from: URL: http://doi.org/10.1007/s40258-018-0419-1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Growth in drug expenditure in EU5 countries likely to decrease. PharmacoEcon Outcomes News 810, 14 (2018). https://doi.org/10.1007/s40274-018-5205-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5205-7

Navigation